Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Cameron

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Thrombolysis|August 4, 2019
Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response teamYu Lin Chen, Colin Wright, Anthony P Pietropaoli, et al.
Blood|March 25, 2017
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditionsMoua Yang, Brian C Cooley, Wei Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2020
Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19Ayman Elbadawi, Islam Y Elgendy, Aditya Sahai, et al.
European Heart Journal. Acute Cardiovascular Care|August 7, 2023
Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism: insights from a national databaseAbdelrhman Abumoawad, Islam Shatla, Leili Behrooz, et al.
The American Journal of Medicine|December 18, 2023
Carotid Duplex Ultrasonography to Assess Severity of Low-Flow Low-Gradient Aortic StenosisMax Puthenpura, Fahad Alkhalfan, Ambreen Fatima Ali, et al.
Vascular Medicine (London, England)|March 6, 2019
National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolismAyman Elbadawi, Amgad Mentias, Islam Y Elgendy, et al.
Journal of Thrombosis and Thrombolysis|January 18, 2023
Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccinationWilliam M Patterson, Brady D Greene, Leben Tefera, et al.
Circulation Research|May 21, 2005
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct sizeMunekazu Yamakuchi, James J M Greer, Scott J Cameron, et al.
FEBS Letters|May 19, 2004
Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusionScott J Cameron, Seigo Itoh, Christopher P Baines, et al.
The Journal of Biological Chemistry|March 19, 2022
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aortaShawna Battle, Valentin Gogonea, Belinda Willard, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Thrombolysis|August 4, 2019
Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response teamYu Lin Chen, Colin Wright, Anthony P Pietropaoli, et al.
Blood|March 25, 2017
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditionsMoua Yang, Brian C Cooley, Wei Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2020
Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19Ayman Elbadawi, Islam Y Elgendy, Aditya Sahai, et al.
European Heart Journal. Acute Cardiovascular Care|August 7, 2023
Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism: insights from a national databaseAbdelrhman Abumoawad, Islam Shatla, Leili Behrooz, et al.
The American Journal of Medicine|December 18, 2023
Carotid Duplex Ultrasonography to Assess Severity of Low-Flow Low-Gradient Aortic StenosisMax Puthenpura, Fahad Alkhalfan, Ambreen Fatima Ali, et al.
Vascular Medicine (London, England)|March 6, 2019
National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolismAyman Elbadawi, Amgad Mentias, Islam Y Elgendy, et al.
Journal of Thrombosis and Thrombolysis|January 18, 2023
Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccinationWilliam M Patterson, Brady D Greene, Leben Tefera, et al.
Circulation Research|May 21, 2005
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct sizeMunekazu Yamakuchi, James J M Greer, Scott J Cameron, et al.
FEBS Letters|May 19, 2004
Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusionScott J Cameron, Seigo Itoh, Christopher P Baines, et al.
The Journal of Biological Chemistry|March 19, 2022
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aortaShawna Battle, Valentin Gogonea, Belinda Willard, et al.
Pageof 13